Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 39.44 USD -0.4% Market Closed
Market Cap: 1.2B USD

Wall Street
Price Targets

CSTL Price Targets Summary
Castle Biosciences Inc

Wall Street analysts forecast CSTL stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSTL is 38.51 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.

Lowest
Price Target
30.3 USD
23% Downside
Average
Price Target
38.51 USD
2% Downside
Highest
Price Target
47.25 USD
20% Upside
Castle Biosciences Inc Competitors:
Price Targets
IDHC
Integrated Diagnostics Holdings PLC
19% Upside
CHE
Chemed Corp
34% Upside
AHX
Apiam Animal Health Ltd
2% Upside
KRSNAA
Krsnaa Diagnostics Ltd
63% Upside
600763
Topchoice Medical Co Inc
16% Upside
002044
Meinian Onehealth Healthcare Holdings Co Ltd
21% Upside
6197
Solasto Corp
36% Downside
QC7
Q & M Dental Group (Singapore) Ltd
3% Downside

Revenue
Forecast

Revenue Estimate
Castle Biosciences Inc

For the last 6 years the compound annual growth rate for Castle Biosciences Inc's revenue is 56%. The projected CAGR for the next 4 years is 7%.

56%
Past Growth
7%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Castle Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Castle Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSTL's stock price target?
Price Target
38.51 USD

According to Wall Street analysts, the average 1-year price target for CSTL is 38.51 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.

What is Castle Biosciences Inc's Revenue forecast?
Projected CAGR
7%

For the last 6 years the compound annual growth rate for Castle Biosciences Inc's revenue is 56%. The projected CAGR for the next 4 years is 7%.

Back to Top